Publications from others using the EDMUS system

Fromont A, Debouverie M, Le Teuff G, Quantin C, Binquet C, Moreau T. Clinical parameters to predict response to interferon in relapsing multiple sclerosis. Neuropidemiology 2008; 31: 150-156.

Petiot V, Quantin C, Le Teuff G, Chavance M, Binquet C, Abrahamowicz M, Moreau T. Disability evolution in multiple sclerosis: how to deal with missing transition times in the Markov model? Neuroepidemiology 2007; 28: 56-64.

Binquet C, Quantin C, Le Teuff G, Pagliano JF, Abrahamowicz M, Moreau T. The prognostic value of initial relapses on the evolution of disability in patients with relapsing-remitting multiple sclerosis. Neurepidemiology 2006; 27: 45-54.

Debouverie M, Lebrun C, Jeannin S, Pittion-Vouyovitch S, Roederer T, Vespignani H. More severe disability of North Africans vs Europeans with multiple sclerosis in France. Neurology 2007; 68: 29-32.

Mikaeoloff Y, Suissa S, Vallée L et al. First episode of acute CNS inflammatory demyelination in childhood: Prognostic factors for multiple sclerosis and disability. Journal of Pediatrics 2004; 144: 246-252.

Mikaeloff Y, Adamsbaum C, Husson B et al. MRI prognostic factors for relapse after a first episode of acute CNS inflammatory demyelination in childhood. Brain 2004; 124: 1942-1947.

Lebrun C, Bourg V, Chanalet S, Chatel M. Maladie inflammatoire du système nerveux central évoluant par poussées avec IRM conventionnelle normale : sclérose en plaques ou phénocopie ? À propos de 15 observations. Rev Neurol (Paris) 2003; 159: 397-404.

Simone IL, Carrara D, Tortorella C, Liguori M, Lepore V, Pellegrini F, Bellacosa A, Ceccarelli A, Pavone I, Livrea P. Course and prognosis in early-onset MS. Comparison with adult-onset forms. Neurology 2002; 59: 1922-1928.

Trojano M, Liguori M, Bosco Zimatore G, Bugarini R, Avolio C, Paolicelli D, Giuliani F, De Robertis F, Marrosu MG, Livrea P. Age-related disability in multiple sclerosis. Ann Neurol 2002; 51 : 475-480.

Simone IL, Carrara D, Tortorella C, Ceccarelli A, Livrea P. Early onset multiple sclerosis. Neurol Sci 2000; 21: S861-S863.

Amato MP, Ponziani G. A prospective study on the prognosis of multiple sclerosis. Neurol Sci 2000; 21: S831-S838.

Bergamaschi R, Romani A, Tonietti S, Citterio A, Berzuini C, Cosi V. Usefulness of Bayesian graphical models for early prediction of disease progression in multiple sclerosis. Neurol Sci 2000; 21: S819-S823.

Liguori M, Marrosu MG, Pugliatti M, Giuliani E, De Robertis F, Cocco E, Zimatore GB, Livrea P, Trojano M. Age at onset in multiple sclerosis. Neurol Sci 2000; 21: S825-S829.

Bernet-Bernardy P, Preux PM, Preux C, Dumas M, Vallat JM, Couratier P. Etude descriptive de 199 patients atteints de sclérose en plaques à partir du programme EDMUS. Revue Neurologique (Paris) 2000; 156: 41-46.

Totaro et al. Prevalence of multiple sclerosis in the L’Aquila district, Central Italy. Journal of Neurology, Neurosurgery and Psychiatry 2000; 68: 349-352.

Martinez YS, Martinez YA, Hernandez RJJ, Martin OG, Arbizu UT. The social and work-related impact of multiple sclerosis. Neurologia 1999; 14 : 107-110 (Spanish).

Cavazzutti M, Merelli E, Tassone G, Mavilla L. Lesion load quantification in serial MRI of early relapsing multiple sclerosis patients in azathioprine treatment. A retrospective analysis. Europ Neurol 1997; 38: 284-290.

Gayou A, Brochet B, Dousset V. Transitional progressive multiple sclerosis: a clinical and imaging study. Journal of Neurology, Neurosurgery and Psychiatry 1997; 63: 396-398.

Edan G, Miller D, Clanet M, Confavreux C, Lyon-Caen O, Lubetzki C, Brochet B, Berry I, Rolland Y, Froment JC, Dousset V, Cabanis E, Iba-Zizen MT, Gandon JM, Lai HM, Moseley I, Sabouraud O. Therapeutic effect of mitoxantrone combined with methylprednisolone in multiple sclerosis: a randomised multi-center study of active disease using MRI and clinical criteria. Journal of Neurology, Neurosurgery and Psychiatry 1997; 62: 112-118.

Trojano M, Avolio C, Manzari C, Simone LL, Defazio G, Manzari C, De Robertis F, Calo A and Livrea P. Soluble intercellular adhesion molecule-1 in serum and cerebrospinal fluid of clinically active relapsing-remitting multiple sclerosis: Correlation with Gd-DTPA magnetic resonnance imaging enhancement and cerebrospinal findings. Neurology 1996; 47: 1535-1541.

Robertson NP, Clayton D, Fraser M, Deans J, Compston DAS. Clinical concordance in sibling pairs with multiple sclerosis. Neurology 1996; 47: 347-352.

Flachenecker P, Hartung HP. EDMUS - a new European databank for multiple sclerosis. A brief introduction of ongoing and planned multicenter studies within the scope of the "European Concentrated Action for Multiple Sclerosis". Nervearzt 1996; 67: 277-82 (German).

Trojano M, Avolio C, Manzari C, De Robertis F, Serio G, Livrea P. Multivariate analysis of predicitive factors of multiple sclerosis with a validate method to assess clinical events. J Neurol Neurosug Psychiat 1995; 58: 300-306.